Showing results (1-10 of 282) with videos related to
Sort By:
Pageof 29
Cell Reports. Medicine|June 22, 2022
Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancerIgor Makhlin, Angela DeMicheleThe Journal of Nutrition|November 11, 2003
Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivorsEdwin Rock, Angela DeMicheleMolecular Diagnosis & Therapy|June 23, 2009
Genomic predictors of outcome and treatment response in breast cancerLara Dunn, Angela DemicheleBreast Cancer Research : BCR|March 21, 2012
Current approaches to the management of Her2-negative metastatic breast cancerKeerthi Gogineni, Angela DeMicheleThe Journal of Targeted Therapies in Cancer|March 27, 2018
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast CancerNicholas McAndrew, Angela DeMicheleAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Neoadjuvant therapy for breast cancer: controversies in clinical trial design and standard of careJulia White, Angela DeMicheleCurrent Oncology Reports|July 23, 2017
Adding Adjuvant Systemic Treatment after Neoadjuvant Therapy in Breast Cancer: Review of the DataShetal A Patel, Angela DeMicheleCurrent Oncology Reports|November 1, 2011
The role of lapatinib in the preoperative therapy of breast cancerRebecca L Hirsh, Angela DeMicheleCurrent Oncology Reports|April 29, 2010
The expanding role of bevacizumab in the treatment of human epidermal growth factor receptor 2-negative breast cancerStephen M Keefe, Angela DemicheleClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
"Braking" the Cycle of Resistance in Endocrine Therapy for Breast CancerAngela DeMichele, Lewis A ChodoshPageof 29